Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Its proven for weight and blood sugar, though so far only approved for weight loss, with a diabetes filing expected later in 2026
In addition to its primary indication for diabetes management, semaglutide is also being explored for its potential benefits in weight management and cardiovascular health, although these uses are considered off-label
But the milliliters you draw change completely
Prevention clinics provide tailored meal plans for optimal protein consumption
Some UHC plans include Wegovy for weight loss or cardiovascular risk reduction, but many do not
US$ 25.78
US$ 25.78
US$ 22.95
US$ 25.91
US$ 27.31
